Table 2.
Proposed SNPs and models with effects on cardiovascular, non-cardiovascular and any death
| rs562020_DOM G (n = 2185) |
rs2283368_DOM C (n = 1017) |
rs2320762_DOM T (n = 2184) |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| GG + AG | AA | P-value | CC + CT | TT | P-value | GG | GT + TT | P–value | ||
| Type of death | n = 1944 | n = 241 | n = 216 | n = 801 | n = 318 | n = 1866 | Whole cohort (n = 2185) | |||
| Cardiovascular death, n (%) | 59 (3) | 3 (1.2) | 0.114 | 7 (3.2) | 27 (3.4) | 0.925 | 11 (3.5) | 51 (2.7) | 0.471 | 62 (2.8) |
| Non-cardiovascular death, n (%) | 101 (5.2) | 7 (2.9) | 0.122 | 22 (10.2) | 33 (4.1) | 0.000 | 26 (8.2) | 82 (4.4) | 0.004 | 108 (4.9) |
| All death, n (%) | 160 (8.2) | 10 (4.1) | 0.026 | 29 (13.4) | 60 (7.5) | 0.006 | 37 (11.6) | 133 (7.1) | 0.006 | 170 (7.8) |
Comparisons between groups were performed with the chi-squared test. Statistically significant values are in bold.